Skip to main content.

Investor Relations

Virtus Announces Gift to Connecticut Children's Medical Center
Gift will support new Cardiovascular Care Center


HARTFORD, Conn., March 14, 2014 – Connecticut Children’s Medical Center has received a $250,000 donation from Virtus Investment Partners of Hartford in support of the hospital’s new Cardiovascular Care Center. Virtus’ leadership generosity, which is the company’s largest donation in its five years as a public company, will fund the Virtus Investment Partners Family Consultation Room in the new Cardiovascular Care Center. The Family Consultation Room will provide a comforting private space where treatment options and outcomes can be discussed with a team of caregivers.

“We are partnering with the medical center on a donation that recognizes our fifth anniversary because Connecticut Children’s is a vitally important institution in the state and has provided exceptional care to so many local residents, including the families of our employees,” said George R. Aylward, President and Chief Executive Officer, Virtus Investment Partners. “The family consultation room will be an integral part of Connecticut Children’s new state-of-the-art cardiovascular care facility, and we are proud to help create this supportive space for families who are coping with the stress of having a child with heart problems.”

Plans for the new Cardiovascular Care Center are underway and will provide the state with the most advanced technology in a space that supports collaboration on diagnosis, treatment and long-term care in a comfortable, family-friendly environment.  With the recent addition of two pediatric cardiovascular surgeons, Connecticut Children’s can meet the needs of patients requiring heart surgery closer to home.

”We are deeply grateful to everyone at Virtus for their leadership support. This project is reliant on donor funds,” said Martha Schall, President of the Foundation for Connecticut Children’s. “With their help, and the help of others they inspired, we are closing in on our goal and moving to planning for this important new asset for the children and families of Connecticut.”

Congenital heart defects are the number one birth defect in the United States. Over 40,000 babies – 1 out of 125 births – are born with one each year. The good news is that most heart imperfections can be corrected or helped with surgery, medicine, or devices.

Last year, Connecticut Children’s Divisions of Cardiology and Cardiovascular Surgery had over 7,500 patient visits.

About Connecticut Children’s Medical Center

Connecticut Children’s Medical Center is a nationally recognized, 187-bed not-for-profit children’s hospital serving as the primary teaching hospital for the Department of Pediatrics at the University of Connecticut School of Medicine. Named among the best inthe nation for several of its pediatric specialties in the annual U.S. News & World Report “Best Children’s Hospitals” rankings, Connecticut Children’s is the only free-standing children’s hospital in Connecticut that offers comprehensive, world-class health care to children. Our pediatric services are available at Connecticut Children’s Medical Center in Hartford and at Saint Mary’s Hospital in Waterbury, with neonatal intensive care units at Hartford Hospital and the University of Connecticut Health Center, along with five specialty care centers and 10 other locations across the state. Connecticut Children’s has a medical staff of nearly 1,100 practicing in more than 30 specialties. For more information, visit or connect with us on Facebook at and Twitter at

About Virtus Investment Partners

Virtus Investment Partners (NASDAQ: VRTS), which is headquarters in Hartford, is a distinctive partnership of boutique investment managers singularly committed to the long-term success of individual and institutional investors. Virtus offers access to a variety of investment styles across multiple disciplines to meet a wide array of investor needs, and provides products and services through affiliated managers and select subadvisers, each with a distinct investment style, autonomous investment process and individual brand.  Additional information can be found at